BlackRock
CTNM

BlackRock’s Contineum Therapeutics CTNM Stock Holding History

BlackRock’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.74M Buy
669,123
+132,968
+25% +$1.78M ﹤0.01% 3582
2025
Q4 		$6.13M Buy
536,155
+214,124
+66% +$2.44M ﹤0.01% 3752
2025
Q3 		$3.78M Buy
322,031
+156,585
+95% +$1.26M ﹤0.01% 3895
2025
Q2 		$657K Sell
165,446
-451,178
-73% -$1.96M ﹤0.01% 4381
2025
Q1 		$4.3M Buy
616,624
+13,047
+2% +$119K ﹤0.01% 3700
2024
Q4 		$8.84M Buy
603,577
+198,805
+49% +$3.15M ﹤0.01% 3488
2024
Q3 		$7.75M Buy
404,772
+8,499
+2% +$163K ﹤0.01% 3535
2024
Q2 		$6.98M Buy
+396,273
New +$6.38M ﹤0.01% 3564

Other funds holding CTNM

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM